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The stress response, essential for life during health and disease, is governed by the 
hypothalamus-pituitary-adrenal (HPA) axis.  It starts by hypothalamic CRH release which, via 
the hypophyseal portal system activates the corticotrophes in the anterior pituitary gland to 
secrete ACTH. ACTH stimulates steroidogenesis by binding to the melanocortin-2-receptor on 
adrenocortical cells. ACTH upregulates expression of this receptor, mediates cholesterol 
release from lipid droplets while activating expression of genes encoding proteins for 
cholesterol uptake and synthesis.1-5 ACTH also increases expression of genes encoding key 
steroidogenic enzymes.1-5 Besides this feed-forward activation of cortisol secretion, feed-back 
inhibition of CRH and ACTH by cortisol occurs at the pituitary and hypothalamic level.  
Within this classical stress response concept, the hypercortisolemia of critical illness is thought 
to be brought about by elevated circulating ACTH which increases adrenocortical cortisol 
production several-fold. However, the few studies that reported plasma ACTH concentrations 
during critical illness showed that these are only elevated briefly and then are lower than 
normal.6-8 This “ACTH-cortisol dissociation” is not what one would expect with a sustained HPA 
axis activation. In fact, Polito et al. reported suppressed ACTH mRNA levels in pituitary glands 
harvested postmortem from 9 patients with septic shock, without a rise in CRH or vasopressin 
expression in the hypothalamus.9 Also in experimental sepsis models, it was recently shown 
that pituitary ACTH expression levels quickly become suppressed,11 possibly explained by 
nitric oxide or by suppressed orexin signaling.9,10 If suppression of pituitary ACTH expression 
would be a primary manifestation of organ damage, this should quickly cause low plasma 
cortisol concentrations, which does not often happen in human ICU patients. Another possible 
explanation is increased adrenocortical sensitivity to ACTH.11 However, the adrenocortical 
cortisol secretory response to a given endogenous plasma ACTH level is not increased during 
critical illness12 and in response to exogenous ACTH often low. Furthermore, a recent study of 
human adrenal glands showed that ACTH signaling was severely suppressed specifically in the 
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prolonged phase of critical illness13, similar to what occurs in POMC deficiency. Hence, a more 
plausible explanation for the high plasma cortisol concentrations with low plasma ACTH levels 
and, with time, reduced ACTH-regulated gene expression in the adrenal cortex, is negative 
feedback inhibition exerted by elevated plasma cortisol that is brought about during critical 
illness by alternative, non-ACTH driven, pathways.  
Although it is generally accepted that cortisol production rate should be >6-fold increased to 
bring about the degree of hypercortisolemia observed during critical illness, it was never 
quantified in ICU-patients until recently. Boonen et al. documented by stable isotopes that 
daytime cortisol production rate was only moderately increased, less than doubled, in critically 
ill patients suffering from the systemic inflammation response syndrome (SIRS) and 
indistinguishable from healthy control subjects in patients without SIRS, while plasma total and 
free cortisol levels were several-fold higher in all patients.8 The stable isotope technique also 
allowed to accurately quantify cortisol plasma clearance, which was found suppressed to less 
than half in all patients, irrespective of inflammation status.8 Cortisol half-life and plasma 
clearance of a 100 mg bolus of hydrocortisone administered during critical illness gave similar 
results: plasma clearance reduced to 40% of normal and a median 5-fold longer cortisol half-
life.8 Reduced cortisol breakdown during illness is due to reduced expression/activity of the 
cortisol metabolizing enzymes in liver and kidney.8 With the knowledge that cortisol half-life and 
plasma clearance is uniformly reduced during critical illness, further study of nocturnal ACTH 
and cortisol secretion rates and the interaction between ACTH concentrations and cortisol 
secretion was recently performed by constructing time series of plasma concentrations 
measured every 10 minutes over 9 hours in critically ill patients and in matched control 
subjects.12 The plasma concentration time series were transformed into hormonal secretion 
profiles with deconvolution analysis, that takes into account elimination half-life of the hormone. 
Both nocturnal ACTH and cortisol pulsatile and total secretion rates were shown to be reduced 
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in critically ill patients.12 Interestingly, the ‘dose-response’ between a given ACTH concentration 
and cortisol secretory response was preserved normal, suggesting that the term ‘ACTH-cortisol 
dissociation’ may not be justified. Indeed, cortisol secretion was still ‘connected’ to circulating 
ACTH, but both were suppressed, not increased, in the presence of high total and free plasma 
cortisol concentrations.12 Together, these new data revealed that overall 24h cortisol 
production rates during critical illness may not be, or at best only moderately, higher than 
during health (Figure).   
 
These new insights have clinical implications. ‘Absolute’ and ‘relative’ adrenal failure may occur 
during critical illness. Absolute adrenal failure can be due to pre-existing adrenal disease, 
adrenocortical hemorrhage, drugs that interfere with cortisol synthesis or adrenal atrophy. The 
latter is due to prolonged ACTH suppression, not only by chronic corticosteroid treatment but 
possibly also, as shown recently, by sustained negative feedback inhibition through 
endogenous cortisol in prolonged critical illness13. Absolute adrenal failure requires immediate 
treatment to prevent a life-threatening Addisonian crisis.  ‘Relative’ adrenal failure is a term that 
was proposed to describe the condition occurring during critical illness in which plasma cortisol 
concentrations, although higher than during health, are insufficiently high to cope with the 
stress level.14 The exact underlying mechanisms remain15 unclear but pituitary 
ischemia/inflammation, more subtle forms of adrenal hemorrhage or target tissue resistance to 
cortisol are thought to play a role. Whether such ‘relative’ adrenal insufficiency needs treatment 
also remains unclear. However, since it is now known that cortisol production is at most only 
moderately increased in critically ill patients with a well-functioning HPA axis, and as cortisol 
breakdown is substantially and robustly reduced, the therapeutic doses of 200 mg or more 
hitherto proposed for absolute and relative adrenal insufficiency, the equivalent of >6-fold the 
normal daily cortisol production, may be too high.  Such high hydrocortisone doses in the 
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presence of severely reduced clearance may accumulate and induce side effects that could 
offset any potential benefit.  
In summary, recent studies showed that increased cortisol exposure for an optimal stress 
response during critical illness is much less determined by cortisol production than by reduced 
cortisol breakdown. These insights have clinical implications that should be further 
investigated. 
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Two sentences summary with key points:  
 
The vital increase in cortisol availability during critical illness appears to be brought about 
primarily by reduced cortisol breakdown rather than by an activated HPA axis or by an 
alternatively activated cortisol production. These new findings explain suppressed plasma 
ACTH through feedback inhibition which, with time, may evoke loss of adrenal gland integrity 
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and function due to lack of adrenocortical ACTH signaling. Also, these new findings have 
implications for correct dosing of hydrocortisone treatment.
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Figure: The differences between the healthy HPA axis and that during critical illness are 
illustrated. Modified and adapted from ref. 16.  
 
  
 
 
 
 
